BiotechTube
Home/ATXA Therapeutics/Professor Therese Kinsella
PT

Professor Therese Kinsella

Founder & CEO

ATXA Therapeutics

Therapeutic Areas

CardiopulmonaryPulmonary Arterial HypertensionHeart FailureInterstitial Lung DiseaseOncology

ATXA Therapeutics Pipeline

DrugIndicationPhase
NTP42Pulmonary Arterial Hypertension (PAH)Phase 1

Leadership Team at ATXA Therapeutics

EM
Eamon Mulvaney
Author/Communications Lead (inferred)
JL
Jonathan Langley
Appointed Role (2020)
View full ATXA Therapeutics profile